Medicare Enrolled

Dr. Alexander Philipovskiy, M.D., PH.D

Medical Oncology · Lake Mary, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
805 CURRENCY CIR, Lake Mary, FL 32746
4078046133
Registered in NPPES since 2010
NPI: 1598074544 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Philipovskiy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Philipovskiy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Philipovskiy

Dr. Alexander Philipovskiy is a medical oncology specialist in Lake Mary, FL, with 15 years of NPI registration. Based on federal Medicare data, Dr. Philipovskiy performed 1,367 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Philipovskiy received a total of $6,735 from 45 pharmaceutical and/or device companies across 181 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Philipovskiy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years of NPI registration ▲ 1,367 Medicare services $6,735 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 155695 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,367
Medicare services
Bottom 49% in FL for medical oncology
Not available
Unique patients (not deduplicated)
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
582 $0 $3
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
251 $8 $9
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
176 $7 $29
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
123 $93 $378
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
82 $22 $84
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
63 $11 $61
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
42 $11 $69
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
20 $50 $189
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
15 $98 $339
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
13 $1 $6
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
16.5% high complexity
51.2% medium
32.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,735
Total received (2018-2024)
Avg $962/year across 7 years
Bottom 49% in FL for medical oncology
45
Companies
181
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,651
2023
$1,067
2022
$345
2021
$78
2020
$136
2019
$130
2018
$2,328

Payments by company (2024)

GENZYME CORPORATION
$542
Novartis Pharmaceuticals Corporation
$227
Merck Sharp & Dohme LLC
$211
AstraZeneca Pharmaceuticals LP
$196
Incyte Corporation
$174
BeiGene USA, Inc.
$157
E.R. Squibb & Sons, L.L.C.
$112
Eisai Inc.
$108
ABBVIE INC.
$98
Takeda Pharmaceuticals U.S.A., Inc.
$96
Janssen Biotech, Inc.
$94
Daiichi Sankyo Inc.
$91
Ipsen Biopharmaceuticals, Inc
$85
Lilly USA, LLC
$63
Gilead Sciences, Inc.
$46
Alexion Pharmaceuticals, Inc.
$45
GlaxoSmithKline, LLC.
$41
JAZZ PHARMACEUTICALS INC.
$38
ARRAY BIOPHARMA INC
$37
PFIZER INC.
$25
Celgene Corporation
$25
SOBI, INC
$23
SpringWorks Therapeutics, Inc.
$22
MorphoSys, US Inc.
$21
EMD Serono, Inc.
$20
Genentech USA, Inc.
$19
TerSera Therapeutics LLC
$19
Mirati Therapeutics, Inc.
$17
Top 3 companies account for 36.9% of 2024 payments
All-time payments by company (2018-2024) ›
Roche Products Limited
$2,198
GENZYME CORPORATION
$542
AstraZeneca Pharmaceuticals LP
$362
Novartis Pharmaceuticals Corporation
$358
Merck Sharp & Dohme LLC
$294
Incyte Corporation
$248
Lilly USA, LLC
$197
E.R. Squibb & Sons, L.L.C.
$186
BeiGene USA, Inc.
$185
Genentech USA, Inc.
$150
PFIZER INC.
$148
Janssen Biotech, Inc.
$145
Adaptive Biotechnologies Corporation
$136
Eisai Inc.
$130
Daiichi Sankyo Inc.
$128
Gilead Sciences, Inc.
$127
ABBVIE INC.
$98
Takeda Pharmaceuticals U.S.A., Inc.
$96
Ipsen Biopharmaceuticals, Inc
$85
Celgene Corporation
$85
ARRAY BIOPHARMA INC
$64
Genmab U.S., Inc.
$61
GlaxoSmithKline, LLC.
$59
JAZZ PHARMACEUTICALS INC.
$58
Seagen Inc.
$56
Pharmacyclics LLC, An AbbVie Company
$52
Alexion Pharmaceuticals, Inc.
$45
TerSera Therapeutics LLC
$44
SOBI, INC
$43
Mirati Therapeutics, Inc.
$38
Merck Sharp & Dohme Corporation
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Sun Pharmaceutical Industries Inc.
$29
Stemline Therapeutics Inc.
$25
TESARO, Inc.
$23
Acrotech Biopharma Inc.
$22
SpringWorks Therapeutics, Inc.
$22
MorphoSys, US Inc.
$21
Bayer HealthCare Pharmaceuticals Inc.
$21
EMD Serono, Inc.
$20
Alnylam Pharmaceuticals Inc.
$18
Astellas Pharma US Inc
$15
Taiho Oncology, Inc.
$14
NOVARTIS PHARMACEUTICALS CORPORATION
$14
Verastem, Inc.
$11
Top 3 companies account for 46.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · BELEODAQ · BRAFTOVI · BRUKINSA · CALQUENCE · CERDELGA · CYRAMZA · Columvi · Copiktra · DOPTELET · Doptelet · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Epkinly · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · REBLOZYL · RYBREVANT · SARCLISA · Stivarga · TAGRISSO · TALZENNA · TECENTRIQ · TUKYSA · Trodelvy · ULTOMIRIS · VERZENIO · Venclexta · XALKORI · XOSPATA · XTANDI · YONSA · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a medical oncology specialist in Lake Mary?
Compare medical oncologists in the Lake Mary area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists in nearby ZIP areas
23
County median income
$83,030
Nearest hospital to ZIP centroid (approximate)
CENTRAL FLORIDA LAKE MONROE HOSPITAL
3.7 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Philipovskiy is a mixed practice specialist, with moderate Medicare volume, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Philipovskiy experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Philipovskiy performed 582 dexamethasone injection (steroid) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Philipovskiy receive payments from pharmaceutical companies?
Yes. Dr. Philipovskiy received a total of $6,735 from 45 companies across 181 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Philipovskiy's costs compare to other medical oncologists in Lake Mary?
Dr. Philipovskiy's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Philipovskiy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →